Here are the DEF 14A proxy statements from Palomino Labs Inc (PALX) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow PALX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PALX filings page.
Palomino Laboratories Inc. (PALX) is asking stockholders to vote at its November 5, 2026 annual meeting on three director seats, ratification of KNAV CPA LLP as auditor for the fiscal year ending December 31, 2026, and an amendment to the 2025 Equity Incentive Plan. The virtual meeting is open to holders of record as of September 23, 2026, when 27,636,539 common shares were issued and outstanding.
If approved, the amendment would set the plan’s share reserve at all times to the greater of 10,000,000 shares or 15% of issued and outstanding common stock on an as-converted basis, effective immediately. The current plan provides for annual increases of up to the lesser of 4.0% of shares outstanding at the prior year-end or a number set by the plan administrator. The nominees are Jeffrey B. Shealy, Steven P. DenBaars and Richard Ogawa; the Board recommends voting FOR all three proposals.